| P50 | author | Christina Ellervik | Q60319049 |
| | Eric Rimm | Q59660391 |
| P2093 | author name string | Michael J Landzberg | |
| | Michael N Singh | |
| | Alexander R Opotowsky | |
| | Brittani Loukas | |
| | Elizabeth I Landzberg | |
| | Lilamarie E Moko | |
| P2860 | cites work | Transcatheter closure of atrial septal defects. Experimental studies | Q69598107 |
| | Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease | Q73668684 |
| | Haemostatic changes following the modified Fontan procedure | Q77564280 |
| | Biorepository and biospecimen science: a new focus for CEBP | Q80293384 |
| | Multicenter research in adult congenital heart disease | Q81507247 |
| | The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010 | Q86313303 |
| | 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Q28239484 |
| | Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support | Q29547407 |
| | Clinical research priorities in adult congenital heart disease | Q30418760 |
| | Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data | Q31044387 |
| | The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine | Q33326512 |
| | HFSA 2010 Comprehensive Heart Failure Practice Guideline | Q34124756 |
| | Model for end-stage liver disease (MELD) and allocation of donor livers | Q34168541 |
| | Angiopoietin-2 in adults with congenital heart disease and heart failure | Q34796161 |
| | The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults | Q34991895 |
| | Management of cardiovascular risk factors in adults with congenital heart disease | Q35114893 |
| | Multiple biomarkers for risk prediction in chronic heart failure. | Q36070049 |
| | Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. | Q36574151 |
| | Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation | Q36877769 |
| | The usefulness of brain natriuretic peptide in simple congenital heart disease - a systematic review | Q38045087 |
| | The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review | Q38047483 |
| | Biomarkers in adult congenital heart disease heart failure | Q38166116 |
| | Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation | Q40565026 |
| | Long-term stability of soluble ST2 in frozen plasma samples | Q43037409 |
| | Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease | Q43236769 |
| | Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis | Q43421507 |
| | Association between N-terminal pro-brain natriuretic peptide and quality of life in adult patients with congenital heart disease | Q43655956 |
| | Trends in hospitalizations for adults with congenital heart disease in the U.S. | Q43994242 |
| | Health care resource utilization in adults with congenital heart disease. | Q44397873 |
| | Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta | Q44904285 |
| | Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. | Q45814687 |
| | Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease | Q46621671 |
| | Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome | Q46693078 |
| | Nephropathy in patients after Fontan palliation | Q46782661 |
| | N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease | Q47855344 |
| | Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease | Q48280472 |
| | High-sensitive troponin-T in adult congenital heart disease | Q48294150 |
| | Long-term stability of endogenous B-type natriuretic peptide after storage at -20 degrees C or -80 degrees C. | Q49140695 |
| | Congenital heart disease in the general population: changing prevalence and age distribution | Q50182262 |
| | Long-term stability of endogenous B-type natriuretic peptide during storage at -20 degrees C for later measurement with Biosite Triage assay. | Q50932082 |
| | Maternal cardiovascular events during childbirth among women with congenital heart disease. | Q51171062 |
| | Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. | Q51564442 |
| | Changing Mortality in Congenital Heart Disease | Q58160541 |
| P433 | issue | 6 | |
| P921 | main subject | congenital disorder | Q727096 |
| | biobank | Q864217 |
| | congenital heart disease | Q939364 |
| P304 | page(s) | 734-743 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | World Journal for Pediatric and Congenital Heart Surgery | Q8035877 |
| P1476 | title | Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank | |
| P478 | volume | 7 | |